Mechanism-based management of taxane-induced neuropathic pain in breast cancer survivors: a critical review.

Breast cancer patients treated with taxane chemotherapy drugs often develop a painful nerve condition called taxane-induced neuropathic pain (TINP), which can significantly impact quality of life. Researchers conducted a comprehensive review to understand how this pain develops and what treatments might help. The study examined both the biological mechanisms behind TINP—including nerve damage, inflammation, and changes in how the nervous system processes pain—and various treatment approaches that target these underlying causes. The review found that several interventions show promise for managing TINP, including medications, physical activity, and manual therapies such as acupuncture and massage. Acupuncture was specifically highlighted as a manual therapy option that may help address the pain pathways involved in this condition. The researchers also examined neuromodulation techniques (both invasive and non-invasive methods that stimulate nerves), as well as cryotherapy (cold therapy). While the results from clinical trials of these various approaches appear encouraging, the authors noted important limitations in existing research, including small numbers of participants, differences in how studies were designed, and the fact that TINP was often not the main focus of investigation. The review concludes that larger, more rigorous studies are needed to better understand which mechanism-based treatments work best for breast cancer survivors experiencing nerve pain from taxane chemotherapy. If you're considering acupuncture for chemotherapy-related nerve pain, consult with a licensed acupuncturist who has experience treating oncology patients.

This critical review examines molecular and cellular mechanisms underlying taxane-induced neuropathic pain (TINP) in breast cancer patients, including mitochondrial dysfunction, oxidative stress, axonal degeneration, maladaptive neuroplasticity, and neuroimmune activation. The authors systematically evaluate clinical and experimental interventions targeting these peripheral and central pathways, including pharmacological treatments, invasive and non-invasive neuromodulation, physical activity, manual therapies (acupuncture and massage), and cryotherapy. While clinical trials demonstrate promising results for these mechanism-based approaches, significant methodological limitations are identified: small sample sizes, heterogeneous study designs, and frequent classification of TINP as a secondary outcome measure. No specific effect sizes or sample sizes are provided in this review article. Clinical takeaway: Multiple therapeutic modalities, including acupuncture, show potential for managing TINP through targeted mechanisms, but higher-quality, mechanism-oriented research with adequate sample sizes and standardized protocols is needed to establish evidence-based treatment guidelines for this debilitating chemotherapy-induced condition.